Ternium S.A.: Ternium Announces Second Quarter and First Half of 2026 Results

Ternium S.A. (NYSE:TX) reported Q2 and first-half 2026 results for the period ended June 30, 2026. Adjusted EBITDA rose sequentially 50% to $717 million, and net income was $465 million. Capex was $431 million. The company expects Q3 2026 Adjusted EBITDA to increase, citing higher shipments and margin improvement.

Original reporting
Published Aug 4, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$TX
Bullish
medium confidence
Mentioned
$TX
Relevance
8/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$TXBullishMed
01

Why it matters

The release combines a quantified Q2 performance beat-style narrative (sequential Adjusted EBITDA up 50%) with a directional Q3 outlook (Adjusted EBITDA expected to increase vs Q2). It also highlights ongoing trade-defense measures (Mexico import measures, Brazil quota renewal, pending antidumping decision) that can affect pricing and volumes.

02

Market read

Traders can use the sequential EBITDA jump, net debt position, and explicit Q3 direction to update near-term expectations for TX, especially given the steel-market and trade-defense catalysts cited for Mexico and Brazil.

03

What to watch

Mining segment performance is tied to realized iron ore prices, and the article excerpt emphasizes price-driven effects; traders may need full segment tables to judge whether steel strength offsets mining volatility.

Relevance 8/10Novelty 8/10Timing: after-hours results release dated Aug 4, 2026

Background

Ternium is a steel and mining company reporting under IFRS interim standards and using non-IFRS metrics like Adjusted EBITDA and Free Cash Flow.

Company-level read

Ticker impact

$TXBullishMedium confidence
Context

Ternium reported Q2 2026 Adjusted EBITDA of $717 million, up 50% sequentially, and guided Q3 EBITDA higher on shipments and margin.

Expected impact

Moderate upside bias for TX into/after the release, assuming the market focuses on the sequential EBITDA jump and the Q3 increase expectation.

Evidence & confidence

The article provides concrete quarterly datapoints (Adjusted EBITDA, net income, net debt) plus a directional Q3 outlook tied to shipments and margin. However, it lacks consensus/estimate context and detailed segment numbers beyond qualitative drivers, limiting precision on magnitude.

Market effects

Steel producers with exposure to Mexico/Brazil may see read-across from Ternium’s commentary on improving fundamentals, import curbs, and quota renewal.

Mexico: strengthening commercial shipments and inventory normalization. Brazil: uneven demand with trade defense gaining ground and an antidumping decision pending.

Trade-defense actions and import substitution themes can influence regional steel pricing and volume expectations beyond Ternium’s own footprint.

Counterpoint

The Q3 EBITDA increase is described as driven by higher shipments and margin, but the margin expansion is only partially offset by higher cost per ton, so upside may be less than bulls expect.

Key entities

  • Ternium S.A.

    Reported Q2 and first-half 2026 results, including Adjusted EBITDA, net income, net debt, capex, and a Q3 EBITDA outlook.

  • Usiminas

    Referenced in adjusted EBITDA reconciliation via ongoing litigation related to acquisition of a participation and reversal of contingencies.

  • Unigal

    Referenced in adjusted EBITDA reconciliation via proportional EBITDA inclusion (70% participation).

Related articles

$DRIMedAI 8/10

DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) reported Q2 2026 results for the quarter ended June 30, 2026: total income $50.1M, total cash receipts $46.5M, and adjusted EBITDA $42.6M. It repurchased 89,513 units at $11.65 and paid a $0.11/unit distribution. After quarter-end, it exercised a put option on Ekterly for about $178M and received FDA approval for Lumvoa (veligrotug), triggering $75M milestone payments.

$LGNDMed

Ligand Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary

Ligand Pharmaceuticals reported Q2 2026 results and discussed its XOMA Royalty acquisition, adding 120+ assets and extending cash flow duration through 2040. Management cited 32% YoY royalty revenue growth and expects 2026 royalty revenue of $225M-$250M with cash opex halved since 2022. Ligand issued a $700M zero-coupon convertible, raised 2026 adjusted EPS guidance to $9.00-$9.50, and expects accretion from XOMA in 2H26 and 2027.

$KDPMed

Keurig Dr Pepper Inc. Q2 2026 Earnings Call Summary

Keurig Dr Pepper reported Q2 2026 results that exceeded expectations, citing double-digit U.S. Refreshment Beverages growth and day-one integration of JDE Peet's. Dr Pepper Zero Sugar grew 30% in retail sales and energy reached 9% market share. U.S. Coffee faced margin pressure from hedging and tariffs. KDP reaffirmed low double-digit EPS growth for 2026 and low-double-digit legacy growth at the high end of 4% to 6%.

$TAPMed

Molson Coors Beverage Company Q2 2026 Earnings Call Summary

Molson Coors reported Q2 2026 volume pressure tied to an energy and inflation shock after conflict in Iran, plus stronger promotions and geopolitical uncertainty in EMEA and APAC. The company reaffirmed FY2026 guidance, citing improving U.S. industry volumes, 1% to 2% annual U.S. price increases, and Midwest Premium aluminum COGS above $130 million, partly hedged. It also outlined a $450 million cost-savings plan and Atomic Brands integration.

$ITTMed

ITT Inc. Q2 2026 Earnings Call Summary

ITT Inc. reported Q2 2026 results driven by 13% organic revenue growth, including 17% at CCT and 21% at Flow Technologies. Full-year organic revenue guidance was raised to 5% to 8% and margin expansion of over 100 bps is expected. Management cited SPX FLOW integration synergies, $71m one-time acquisition costs, and Middle East order delays.